Abstract. Reactive carbonyl compounds (RCCs) are ubiquitous in the environment and are generated endogenously as a result of various physiological and pathological processes. These compounds can react with biological molecules inducing deleterious processes believed to be at the basis of their toxic effects. Several of these compounds are implicated in neurotoxic processes, aging disorders, and cancer. Therefore, a method characterizing exposures to these chemicals will provide insights into how they may influence overall health and contribute to disease pathogenesis. Here, we have developed a high resolution accurate mass (HRAM) screening strategy allowing simultaneous identification and relative quantitation of DNPHderivatized carbonyls in human biological fluids. The screening strategy involves the diagnostic neutral loss of hydroxyl radical triggering MS 3 fragmentation, which is only observed in positive ionization mode of DNPH-derivatized carbonyls. Unique fragmentation pathways were used to develop a classification scheme for characterizing known and unanticipated/unknown carbonyl compounds present in saliva. Furthermore, a relative quantitation strategy was implemented to assess variations in the levels of carbonyl compounds before and after exposure using deuterated d 3 -DNPH. This relative quantitation method was tested on human samples before and after exposure to specific amounts of alcohol. The nano-electrospray ionization (nano-ESI) in positive mode afforded excellent sensitivity with detection limits on-column in the highattomole levels. To the best of our knowledge, this is the first report of a method using HRAM neutral loss screening of carbonyl compounds. In addition, the method allows simultaneous characterization and relative quantitation of DNPH-derivatized compounds using nano-ESI in positive mode.
Introduction
C arbonyl compounds are a major component of the exposome, a term that was introduced to describe the totality of chemical exposures in an individual's life-time [1] .
These compounds are ubiquitous in the environment and are generated endogenously in the body through a variety of metabolic and physiological processes. Exposure to carbonyl compounds can result from numerous sources: air pollution, fossil fuel combustion, industrial processes, as well as foods and beverages in which they are used as flavorings [2] . Endogenously, carbonyl compounds can originate from the body's metabolism, from processes such as oxidative stress and lipid peroxidation, and from the interaction of the body with the microbiome [3] . These electrophilic compounds are reactive and can covalently bind to the nucleophilic sites of peptides, proteins, lipids, DNA, and RNA, inducing modifications, which are at the base of their mechanism of toxicity. Exposure to RCCs is associated with a wide variety of aging-and oxidative stress-related diseases. Among these compounds, formaldehyde and acetaldehyde have been classified as carcinogenic to humans by IARC [4, 5] . Exposure to these compounds results from a combination of exogenous sources and endogenous processes, and little is known about the overall identity and abundance of RCCs in relevant biological fluids and consequently the levels of overall human exposure. A method to screen and characterize RCCs in biological samples accounting for both endogenous and exogenous sources is important to gain insights into how specific exposures influence overall health and disease etiology.
Characterization and quantitation of RCCs are typically accomplished by derivatization with 2,4-dinitrophenylhydrazine (DNPH) to form their corresponding hydrazones. The carbonyl-hydrazones are then analyzed using HPLC-UV and LC/MS [6] [7] [8] . Derivatization is performed to increase the molecular weight of small and polar aldehydes, thereby increasing their retention and ionization during LC-UV and LC/MS analyses, respectively [9] . DNPH derivatization of RCCs has been widely used in environmental monitoring of air and water quality [9] [10] [11] [12] [13] [14] , in the food industry [15] [16] [17] , and in biomedical research [18] [19] [20] . Although HPLC-UV is routinely used to quantify these carbonyls, the identity of unanticipated and unknown compounds cannot be determined using this method without authentic internal standards. In addition, co-eluting peaks during LC separation can further confound the identification and quantitation of carbonyl compounds via UV.
Mass spectrometry-based approaches are used extensively to measure DNPH-derivatized carbonyl compounds because of the molecular weight and structural information obtained during analysis. Different ionization techniques have been employed, including atmospheric pressure chemical ionization (APCI) [12, 14, [21] [22] [23] , atmospheric pressure photoionization (APPI) [13] , and electrospray ionization (ESI) [10, 11, 18, 19, 24] . The MS/ MS and MS n spectra have been used to identify unique fragment ions for structural elucidation [12, 25, 26] . These studies described the MS and MS/MS behavior of DNPH-derivatized carbonyls in negative ionization mode, whereas the behavior of these compounds in positive mode is poorly understood. Recent studies reported characterization of DNPH-derivatized malondialdehyde using ESI in positive mode [27, 28] . In addition, ESI(+) has been used to characterize carbonyl compounds derivatized with various labeling agents including 4-(2-(trimethylammonio)ethoxy)benzenaminium halide (4-APC) [29] and 2,4-bis(diethylamino)-6-hydrazino-1,3,5-triazine [30] . The relatively high flow rates used in these studies, however, limit the sensitivity for detection and quantitation of trace level analytes.
Here, we have developed a high resolution accurate mass MS 3 neutral loss screening strategy for all DNPH-derivatized carbonyls in biological fluids, allowing the simultaneous detection and quantitation of suspected and unknown/ unanticipated carbonyl compounds. The characteristic neutral loss of the hydroxyl radical,
• OH from DNPH-derivatized carbonyl compounds in positive ionization mode, allows unambiguous identification of RCCs. The neutral loss of
• OH is not observed in negative mode ESI of the compounds investigated in this study. Furthermore, a relative quantitation strategy using isotope labeling with deuterated d 3 -DNPH was implemented to determine the relative levels of carbonyl exposures. Limits of detection (LOD) in the high-attomole range on-column were obtained. The MSbased workflow presented here provides an accurate, rapid, and robust method to identify and quantify toxic and carcinogenic carbonyls in various biological matrices. This is in contrast to previous work, which used relatively high flow rates (0.2 mL min -1 to 1.5 mL min -1 ) and low resolution MS analysis, limiting their sensitivity and confident identification for trace analyte levels.
Experimental
Materials 2,4-Dinitrophenylhydrazine (DNPH) was purchased from Tokyo Chemical Industry (Portland, OR, USA); d 3 -labeled DNPH (>98% isotopic purity) and malondialdehyde (MDA) were obtained from Santa Cruz Biotechnology (Dallas, TX, USA); Ketones Mix (propanone, 2-butanone, 4-methyl-2-pentanone, 2-hexanone, cyclohexanone) and TO11/IP-6A Aldehyde/Ketone-DNPH Mix (acetaldehyde-DNPH, propanone-DNPH, propanal-DNPH, acrolein-DNPH, benzaldehyde-DNPH, butanal-DNPH, crotonaldehyde-DNPH, 2,5-dimethylbenzaldehyde-DNPH, formaldehyde-DNPH, hexanal-DNPH, pentanal-DNPH, isopentanal-DNPH, otolualdehyde-DNPH, m-tolualdehyde-DNPH, p-tolualdehyde-DNPH), 4-hydroxy-3-methoxybenzaldehyde (Vanillin), indole-3-carboxaldehyde, hexanophenone, heptanophenone, 2,3-butanedione, 2,3-pentanedione, trans-2-methyl-2-butenal, 3-methyl-2-butenal (methylcrotonaldehyde), sodium acetate, and concentrated HCl were obtained from Sigma Aldrich (Milwaukee, WI, USA); 13 C 2 -acetaldehyde was obtained from Cambridge Isotope Laboratories (Tewksbury, MA, USA); methylglyoxal (MG) was obtained from Thermo Fisher (Morris Plains, NJ, USA); Strata-X polymeric reverse-phase cartridge was purchased from Phenomenex (Torrance, CA, USA). All acids and organic solvents were HPLC grade or better.
Sample Collection and DNPH Derivatization
Human saliva samples were collected from the ongoing research study BAcetaldehyde-derived DNA adducts for the investigation of alcohol hangover^at the University of Minnesota, approved by the Institutional Review Board (IRB). In this study, healthy non-smoking volunteers were exposed to a specific amount of alcohol. Pre-exposure saliva samples were collected before alcohol consumption. Subjects were then administered a specific amount of vodka to reach a BAC of 0.11%. After 1 h, post-exposure saliva samples were collected.
The samples were frozen and stored -20°C until further analysis. Frozen samples were thawed, centrifuged to remove debris, and derivatized with DNPH to form their corresponding hydrazones. The reaction was performed and optimized as previously described with minor modifications [31] . Briefly, 100 μL of saliva was derivatized with excess amounts of DNPH (400 μL of 1 mg/mL in 6N HCl) for 1 h with shaking at room temperature. Thereafter, the reaction was quenched by adding 1.2 mL of 3 M sodium acetate. The resulting hydrazones were partially purified by Strata-X reverse-phase solid phase extraction (SPE). The cartridge was conditioned with 1 mL methanol, then equilibrated with 1 mL water. The sample was then loaded into the cartridge and allowed to flow through by gravity. The cartridge was washed with 1 mL water and 4 mL 60% methanol. The hydrazone products were finally eluted using 4 mL 100% acetonitrile. A 100 μL aliquot was dried and resuspended in 100 μL 20% methanol. One 1 μL of the sample was used for LC/MS analysis.
LC/MS Parameters
A data-dependent neutral loss acquisition method was used to screen for all DNPH-derivatized carbonyl compounds. The analysis was performed on a Thermo LTQ Orbitrap Velos (Thermo Scientific, Waltham, MA, USA) mass spectrometer coupled to a Dionex RSLC HPLC (Thermo Scientific, Sunnyvale, CA, USA). Reverse phase chromatography on a homepacked Acclaim C8 column (5 μm, 120 Å, 100 mm × 75 μm, Thermo Scientific, Waltham, MA, USA) was performed at room temperature and flow rate of 0.3 μL min -1 using 0.1% formic acid as mobile phase A and methanol as mobile phase B. One μL of the sample was injected on-column. Gradient elution was carried out starting with 5% B for the first 5 min with a flow rate of 1.0 μL min -1 . The flow rate was reduced to 0.3 μL min -1 over 2 min, with switching of the injection valve position at 6 min into the run to take the 5 μL injection loop out of the flow path. A linear gradient from 5% to 98% B over 23 min was employed followed by a constant 98% B for 10 min. Finally, a linear gradient from 95% to 5% B over 3 min was carried out and the flow rate was increased to 1.0 μL min -1 within 2 min. The column was re-equilibrated at 5% B for another 5 min. The total run time was 50 min. The nanoelectrospray voltage was set to 2.2 kV with a source temperature of 350°C. An automated instrument tuning feature while monitoring the background ion signal m/z 371.10 (decamethylcyclopentasiloxane) was used to generate the tune file for all LC/MS analysis. The ion focusing and transfer elements were optimized for maximum signal intensity, which resulted in a S-Lens rf setting of 60%. The LTQ Orbitrap Velos mass spectrometer was routinely calibrated using the Pierce LTQ ESI Positive Ion Calibration Solution (Thermo Scientific, Rockford, IL, USA). In addition, the mass accuracy (<5 ppm) o f t h e s i g n a l o f a n a b u n d a n t b a c k g r o u n d i o n , decamethylcyclopentasiloxane (m/z 371.10124), was evaluated before analysis. Instrument sensitivity and mass accuracy were checked using a mixture of synthetic DNPH-derivatized carbonyls (TO11/IP-6A Aldehyde/Ketone-DNPH Mix; Sigma-Aldrich, Milwaukee, USA) before all LC/MS analysis.
Data-Dependent MS 3 Neutral Loss Screening
Data-dependent MS 3 neutral loss screening was performed in positive ionization mode with full scan detection (m/z 170-500), followed by data-dependent CID fragmentation of the top five most intense ions, and MS 3 CID fragmentation triggered upon observation of the neutral loss of the 
Relative Quantitation Strategy
Pre-exposure samples (before drinking) were derivatized as described above with unlabeled DNPH (d 0 -DNPH) whereas post-exposure samples (after drinking) were derivatized with d 3 -labeled DNPH (Supplementary Figure 1) . A 1:1 ratio of d 0 -DNPH (derivatized pre-exposure saliva, 100 μL) and d 3 -DNPH (derivatized post-exposure saliva, 100 μL) were combined, dried, and resuspended in 100 μL 20% methanol before LC/MS analysis. One μL of the sample was injected on column. Mass spectral data were analyzed using Xcalibur 3.0.63 (Thermo Scientific, San Jose, CA, USA), with manual evaluation of the spectra for structural characterization of the DNPHderivatized carbonyls. For quantitative analysis, extracted ion current (EIC) chromatograms (5 ppm mass tolerance) of d 0 -DNPH-labeled and d 3 -DNPH-labeled hydrazone products were generated and peak areas integrated and expressed as fold change (d 3 -DNPH/d 0 -DNPH). For the LOD determination, the matrix (pooled saliva samples, n = 4) was spiked with synthetic d 0 -DNPH-derivatized RCC standards at different levels and analyzed by LC-MS. Because endogenous RCCs are present in saliva, samples were derivatized with d 3 -DNPH prior to spiking so that the endogenous RCCs would have different masses (3 Da) than the spiked synthetic d 0 -DNPH-derivatized RCCs and therefore would not contribute to their extracted ion signals.
Results and Discussion

Characterization of DNPH-Derivatized Carbonyls Using Nano-ESI Mass Spectrometry
Previous studies on LC/MS analysis of DNPH-derivatized carbonyls were carried out using APCI, APPI, and ESI in negative ionization mode at relatively high-flow rates (0.2-1.5 mL min -1 ). To date, no literature has described the behavior of these compounds in nano-electrospray and positive ionization mode. To increase the sensitivity of detecting and quantifying trace level analytes, we have investigated nano-LC separation (300 nL min ) of DNPH-derivatized carbonyls and studied their behavior using nano-ESI in both positive and negative ionization modes.
The nano-ESI spectra of DNPH-derivatized carbonyls in positive mode yielded higher ion abundances of the protonated precursor
ions [M + H] + compared with the deprotonated precursor ions [M -H]
-in negative mode ( Figure 1a ). Except for formaldehyde-DNPH, all of the aldehydes tested exhibited signal intensities 2-16 times higher in positive mode than in negative mode. For instance, the protonated precursor ion of acetaldehyde-DNPH (m/z 225.0618) is eight times more abundant than its deprotonated precursor ion (m/z 223.0472). While nitro aromatic compounds are best ionized by ESI or APCI in negative mode, amino-containing nitro aromatic compounds, such as DNPH, ionize well using electrospray in positive mode [32] . In fact, we observed higher ion abundances for most, if not all, DNPH-derivatized carbonyls investigated in this study. Moreover, the CID or HCD fragmentation of the protonated precursor ion of DNPH-derivatized carbonyls yielded a base peak corresponding to the loss of a common functional group (Figure 1b) . The CID or HCD fragmentation of the deprotonated precursor ions [M -H] -, on the other hand, gave extensive fragmentation, which is consistent with the findings of Kolliker and co-workers [25, 26] (Figure 1c ). Since our focus was on developing a screening strategy, the neutral loss observed in the MS 2 spectra was used to trigger MS 3 for all derivatized carbonyls. High resolution accurate mass analysis confirmed that this neutral loss is due to the loss of the hydroxyl radical (
• OH, 17.0027 Da). Without accurate mass spectral data, this neutral loss could also be attributed to the loss of NH 3 (17.0266 Da).
To confirm that the loss of the hydroxyl radical is from the DNPH portion of DNPH-derivatized carbonyls, we performed CID fragmentation of the protonated precursor ion Figure 2a , b. The analogous negative ions, m/z 76 and 163, respectively, were previously observed in MS 2 of DNPH using negative ion APCI [25] .
The loss of the hydroxyl radical is diagnostic of nitro aromatic compounds after CID of the [M + H] + ion [32] . We did not observe this neutral loss in negative mode. Moreover, the amino group in DNPH makes it ideal for protonation and, thus, easily detectable during MS analysis in ESI positive ionization mode, consistent with our observations and those of Levsen et al. (2007) [32] . Therefore, analysis of the DNPHderivatized carbonyls in positive mode provides additional specificity for DNPH-derivatized carbonyl compound identification. The high mass accuracy acquisition of our method, typically less than 5 ppm mass error, allows unambiguous identification of elemental compositions of all precursor ions as well as fragment ions (restricting elements to C, N, O, H) (Figure 2a, b) . Different collision energies (CE) were then investigated using both HCD and CID to determine the optimal CE to obtain maximum base peak attributable to the loss of and 164.0323) was used to confirm the detection of DNPHderivatized carbonyls. (Figure 3a) .
Principles of the Neutral Loss Screening Strategy
The neutral loss screening strategy simplifies the data analysis and structural characterization of DNPH-derivatized carbonyls. For instance, LC/MS analysis of mixture of standards in water yielded~3600 MS 2 spectra, whereas the additional MS 3 triggering upon loss of 
Classification Scheme as a Guide for the Structural Analysis of Known and Unknown DNPH-Derivatized Carbonyls
A classification scheme for the structural analysis of known and unknown DNPH-derivatized carbonyls was developed using the high resolution accurate masses of the MS 2 and MS 3 mass spectral data of all DNPH-carbonyl standards used for our method development (Figure 4) . The scheme and the differences in fragmentation pathways are used to differentiate between saturated aldehydes, unsaturated aldehydes, aromatic aldehydes, and ketones. A similar scheme was developed using the MS 2 and MS n fragmentation data obtained using APCI in negative ionization mode [25] . In our current approach, however, the high resolution accurate mass data (typically <5 ppm mass error) were used to unambiguously assign the molecular formula of both precursor ions and fragment ions. For instance, high molecular weight (HMW) carbonyls differ from low molecular weight ones (MW > 260 Da) by the loss of 183.0274 Da (C 6 H 5 O 4 N 3 ) due to the loss of DNPH resulting from the cleavage of the N-N bond of the hydrazine portion during MS 2 fragmentation ( Supplementary Figure 8a, b) . We observed that as the MW of the carbonyl compound increases, the intensity of the signal attributable to the loss of 183 Da increases (data not shown). In addition, we observed the fragmentation behavior/pattern is somewhat different with HMW carbonyl compounds; in particular, fragment ions coming from the carbonyl portion are apparent in the Figure 2) . Unsaturated aldehydes such as acrolein-DNPH and crotonaldehyde-DNPH, on the other hand, showed a loss of 48.0086 Da in the MS 3 , which is due to the neutral loss of the molecular formula corresponding to H 2 NO 2 (Supplementary Figure 4) . The APCI (-) spectra of unsaturated aldehydes showed similar fragment ion due to the loss of 47 (HNO 2 ) [25] . Interestingly, the appearance of specific ions, m/z 78.0332 and 164.0323 in the MS 3 spectra of saturated aldehydes is prominent, while these ions are absent or less intense in the MS 3 spectra of unsaturated aldehydes. Thus, the presence and intensity of diagnostic fragment ions (m/z 78.0332 and 164.0323) could be used to differentiate saturated/aliphatic carbonyls from unsaturated/aliphatic carbonyls. Aliphatic aldehydes can be differentiated from aliphatic ketones by the appearance of characteristic ions in the MS 2 spectra. Aliphatic aldehydes showed a characteristic ion, m/z 164.0454, whereas aliphatic ketones showed a characteristic ion at m/z 178.0611 ( Supplementary Figures 2 and 5) . The general scheme for differentiating aliphatic aldehydes from aliphatic ketones and the proposed fragmentation pathways leading to the ions m/z 164.0454 and 178.0611 are shown in Supplementary  Figure 9a . For instance, the isobaric carbonyls, hexanal-DNPH, 2-hexanone-DNPH, and 4-methyl-2-pentanone-DNPH, can be differentiated using the appearance of the ions, m/z 164.0454 and 178.0611 in the MS 2 spectra (Supplementary Figure 9b) . The m/z 164.0454 is only present in hexanal-DNPH, whereas m/z 178.0611 is only present in 2-hexanone and 4-methyl-2-pentanone (Supplementary Figures 2 and 5) .
The m/z 190.0483 in an MS 3 spectra can be used to further differentiate hexanal from its isobaric compounds, 2-hexanone and 4-methyl-2-pentanone. The m/z 190.0483, which corresponds to the molecular formula C 8 H 6 O 2 N 4 , results because of the loss of the alkyl and hydroxyl groups as shown in Supplementary Figure 9c . This ion is also formed in butanal, pentanal, and isopentanal (Supplementary Figure 2d-g) ; however, it is not observed in the MS 3 spectra of aliphatic ketones, 2-butanone, 2-hexanone, and 4-methyl-2-pentanone. Thus, the presence of m/z 190.0483 in an MS 3 spectrum can be used to classify an isobaric aliphatic aldehyde from its aliphatic ketone counterpart. However, at this point, we are not able to differentiate the isomeric ketones, 2-hexanone from 4-methyl-2-pentanone, based on the MS 2 and MS 3 fragmentation data for these compounds.
The appearance of m/z 193.0356 and 138.0424 in the MS 2 spectra is also indicative of aliphatic aldehydes, whereas the presence of m/z 207.0513 is indicative of aliphatic ketones. The m/z 193.0356 and 207.0513, however, are both observed in the MS 2 spectra of propanal-DNPH and propanone-DNPH probably because of the similar structures of the fragment ions formed after the loss of the ethyl group in propanal-DNPH and the two methyl groups in propanone-DNPH upon fragmentation. The fragmentation pathways leading to these characteristic ions in aliphatic aldehydes and ketones are shown in Supplementary Figure 9d . Figure 4 . Classification scheme for characterizing known and unknown DNPH-derivatized carbonyls. Proposed fragmentation pathways and structures of neutral losses and characteristic ions used for structural elucidation are shown in Supplementary  Figures 8 and 9 Application of the NL Screening Strategy to Human Saliva Samples After Alcohol Exposure
To test the applicability of the method for the simultaneous screening and quantitation of carbonyls in saliva, a human model system for alcohol exposure was used [3, 33] . In our study, healthy non-smoking volunteers were administered amounts of vodka to reach a BAC of~0.11, after which the identity and the levels of carbonyl compounds were determined. The classification scheme was then used for the structural analysis of detected unanticipated and unknown carbonyl compounds. For instance, an unanticipated compound was detected and identified in saliva. The MS 2 spectrum of the compound exhibited a base peak due to the loss of • OH (Figure 5a ). The second most abundant fragment ion is the loss of 183.0274 Da due to DNPH, consistent with a carbonyl compound of a high molecular weight (MW > 260 Da). The MS 3 spectrum showed no loss of 163.0250 and 29.9980 Da, suggesting an aliphatic carbonyl. The MS 3 showed characteristic loss of 48.0086 Da (loss of H 2 NO 2 ) suggesting an unsaturated aldehyde and a base peak at m/z 233.0659 Da corresponding to the loss of methyl group (Figure 5b) . These results suggest the compound is unsaturated and methylated carbonyl. The high resolution accurate masses of the protonated precursor ions and both the MS 2 and MS 3 data are consistent with the identification of the isomeric compounds, 3-methyl-2-butenal (methyl crotonaldehyde) or trans-2-methyl-2-butenal. The identity of the compound was confirmed by DNPH-derivatization of synthetic standards of 3-methyl-2-butenal (methyl crotonaldehyde) and trans-2-methyl-2-butenal. The MS 2 and MS 3 fragmentation mass spectral data and retention time of the unanticipated compound are consistent with 3-methyl-2-butenal (methyl crotonaldehyde) ( Figure 5c ).
Next, we determined and quantified the levels of carbonyls after exposure to an alcoholic beverage (vodka). Pre-exposure (baseline) and post-exposure saliva were labeled with d 0 -DNPH and d 3 -DNPH, respectively. The relative abundances of the ions corresponding to d 0 -DNPH-labeled carbonyls and d 3 -DNPH-labeled carbonyls were determined by integrating the peak areas in the full scan EIC chromatograms and expressed as fold change (post-exposure/pre-exposure; d 3 -DNPH/d 0 -DNPH). The EIC chromatograms of d 0 -DNPH-labeled acetaldehyde and d 3 -DNPH-labeled acetaldehyde showed co-eluting peaks at the same retention times, whereas the mass spectrum of d 0 -DNPH-labeled acetaldehyde and d 3 -DNPH-labeled acetaldehyde pairs showed MS signals separated by 3 Da (Figure 6a, b) . Because the ionization efficiencies are similar for both d 0 -DNPH-labeled and d 3 -DNPH-labeled carbonyl compounds, accurate relative quantitation can be performed.
The acetaldehyde levels in saliva samples of four subjects exhibited four to seven times higher after alcohol exposure (Figure 6c) , which is in agreement with previous studies [3, 33] . In fact, even a single sip of strong alcoholic beverage can instantly cause increased acetaldehyde levels in the oral cavity [3] . Benzaldehyde was also increased in the four subjects probably due to the flavorings present in the alcoholic beverage (vodka). Likewise, several isomers of hydroxybutanone were detected eluting at different times but the identity of each isomer cannot be deduced at this point without internal standards corresponding to the different isomers. While we expected elevated levels of acetaldehyde after alcohol exposure, most of the other carbonyls identified showed no dramatic change in the amounts (dotted line, Figure 6c) ; however, variability in the levels is observed among the four subjects due to interindividual variation (Figure 6c) .
The LOD of DNPH-derivatized carbonyls was determined and is defined here as the lowest concentration of the analyte where the signals corresponding to the desired analytes resulted in a clear Gaussian peak in the EIC chromatograms (5 ppm mass Tables 1 and 2 ). Although some aldehydes showed increased LOD in saliva (e.g., formadehyde-DNPH), the matrix did not adversely affect the overall LOD of most carbonyl compounds. For instance, the LOD of acetaldehyde-DNPH obtained using the current approach (LOD: 0.04 pg) is 150 times lower than that obtained by Ochs et al. (LOD: 5.97 pg) using SRM and APCI in negative ionization mode [14] . The LOD for several RCCs known to be present in biological samples were determined; however, there are potentially many other RCCs that may be present in saliva for which the LOD was not measured. There are primarily two factors determining the LOD for a given RCC using the methodology described here. First, the ion abundance in the full scan spectrum must be greater than the data-dependent acquisition (DDA) threshold so that it is eligible to be selected for MS 2 fragmentation. Secondly, even though the ion intensity is above the threshold, it still must be selected via DDA for MS 2 fragmentation. DDA is stochastic in nature and therefore even though a given carbonyl compound ion has an intensity above the DDA threshold in the MS 1 spectra, it may not be sampled for MS 2 fragmentation and therefore not detected. Currently, improvements in sample cleanup and the use of newer, more sensitive MS technology with faster HRAM scanning capabilities are being investigated to obtain lower LOD and improved detection of low abundant DNPH-derivatized carbonyls. The technical and experimental reproducibility of the method was assessed using pooled saliva samples (n = 4) spiked with 13 C 2 -acetaldehyde (50 fmol on-column). The technical reproducibility was evaluated using three replicate preparations of the samples on the same day and analyzed using the screening method. The EICs corresponding to the 13 C 2 -acetaldehyde-DNPH were integrated in the three replicate preparations and expressed as %CV. Likewise, the experimental reproducibility was evaluated using three different preparations of the samples on different days and analyzed using the approach. The EICs corresponding to the 13 C 2 -acetaldehyde-DNPH were integrated in the three different days of sample preparation and expressed as %CV. The technical reproducibility of the quantitation was determined to be 6%, whereas the experimental reproducibility was 11%.
Although the current approach worked well with nearly all the aldehydes and ketones investigated, we found that carbonyls containing hydroxyl groups in the aliphatic chain and dicarbonyl compounds behave somewhat differently than the others. The CID MS 2 fragmentation spectra of dicarbonyl-hydrazones, such as 2,3-butanedione-DNPH and 2,3-pentanedione-DNPH, yielded dominant m/z attributed to the loss of water (18. Figure 7b) . Further interrogation of the MS 2 data found the dominant peak for 2,3-pentanedione-DNPH due to the loss of water. In addition, hydroxylated aldehydes/carbonyls detected in saliva yielded similar MS 2 spectra showing the loss of water. For dicarbonyls and hydroxylated carbonyl compounds, we are currently investigating the loss of water as an additional feature of the screening method. Because it is not as diagnostic as the loss of hydroxyl radical to screen for DNPH-derivatized compounds as it is a common feature of many molecules in biological samples, we are now investigating the fragmentation behavior of this class of compounds. Preliminary observations of analyzed samples suggest that the MS 2 fragmentation of the dicarbonyls and hydroxylated carbonyl compounds results in loss of H 2 O and the subsequent MS 3 fragmentation results in the loss of the OH, presumably from the DNPH portion of the molecule. This suggests that the neutral loss of H 2 O and the subsequent loss of OH could be used to trigger another fragmentation event (MS 4 ) allowing for screening and characterization of this class of compounds. Lastly, monitoring the appearance of specific ions due to the derivatizing agent and the carbonyl portion of DNPHderivatized carbonyls can allow confirmation and identification of dicarbonyls and hydroxylated carbonyl compounds. Additional investigations with synthetic standards of this class of compounds need to be done to confirm these observations.
Conclusions
Overall, a high resolution accurate mass data-dependent MS 3 neutral loss screening for aldehydes/ketones in saliva was developed. The improvements provided by the new approach include: (1) the high resolution accurate mass analysis (<5 ppm) enabling confident identification of DNPH-derivatized carbonyls; (2) NL screening (
• OH) and MS 3 data acquisition in positive mode allowing identification of known and structural characterization of unknown carbonyls; (3) nano-ESI affords excellent sensitivity with detection limits in the high-attomole levels; (4) a relative quantitation strategy enabling determination of the levels of compounds after exposure.
The approach developed here provides several levels of selective identification and characterization of target analytes in biological samples. First, the highly selective reaction of DNPH with carbonyl compounds such as aldehydes and ketones enables detection of derivatized carbonyl compounds. Secondly, the characteristic loss of hydroxyl radical used to trigger MS 3 fragmentation, which is only observed in positive ionization of amino nitro aromatic compounds, allows selective detection and fragmentation of DNPH-derivatized carbonyls. Lastly, the appearance of specific fragment ions due to the derivatizing agent minimizes possible false-positive identification. The approach developed here will be useful in characterizing toxic and genotoxic carbonyl compounds resulting from specific exposures and for monitoring endogenous formation of carbonyl compounds such as those derived from processes related to inflammation like lipid peroxidation and oxidative stress. To the best of our knowledge, this is the first report of the high resolution accurate mass neutral loss screening and characterization of DNPH-derivatized carbonyls using nano-ESI in positive ionization mode. Furthermore, the relative quantitation strategy using deuterated d 3 -DNPH provides a versatile tool for quantifying carbonyls present in a variety of biological matrices.
